Chronic migraine in women is associated with insulin resistance: A cross-sectional study

European Journal of Neurology

Volumn 21, Issue 2, 2014, Pages 267-272

  Fava, A ^a   Pirritano, D ^b   Consoli, D ^c   Plastino, M ^b   Casalinuovo, F ^b   Cristofaro, S ^b   Colica, C ^d   Ermio, C ^e   De Bartolo, M ^f   Opipari, C ^b   Lanzo, R ^b   Consoli, A ^g   Bosco, D ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b S Giovanni di Dio Hospital   (Italy)

^c G Jazzolino Hospital   (Italy)

^d INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^e S Giovanni Paolo II Hospital   (Italy)

^f General Hospital   (Italy)

^g CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Chronic migraine; Episodic migraine; Insulin resistance; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PROLACTIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EPISODIC MIGRAINE; FEMALE; GLUCOSE BLOOD LEVEL; HEADACHE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK FACTOR; TRANSFORMED MIGRAINE; WAIST CIRCUMFERENCE;

CHRONIC MIGRAINE; EPISODIC MIGRAINE; INSULIN RESISTANCE; METABOLIC SYNDROME;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; MIGRAINE DISORDERS; OBESITY; WAIST CIRCUMFERENCE;

EID: 84892483176     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12289     Document Type: Article

References (37)

1. Lipton RB, Bigal ME. Looking to the future: research design for study of headache disease progression. Headache 2008; 48: 58-66.
2. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edn (beta version). Cephalalgia 2013; 33: 629-808.
3. Zwart JA, Dyb G, Hagen K, et al. Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 2003; 10: 147-152.
4. Peterlin BL, Tietjen G, Meng S, Lidicker J, Bigal M. Post-traumatic stress disorder in episodic and chronic migraine. Neurology 2008; 48: 517-522.
5. Hagen K, Einarsen C, Zwart JA, Svebak S, Bovim G. The co-occurrence of headache and musculoskeletal symptoms amongst 51, 050 adults in Norway. Eur J Neurol 2002; 9: 527-533.
6. Peres MF, Young WB, Kaup AO, Zukerman E, Silberstein SD. Fibromyalgia is common in patients with transformed migraine. Neurology 2001; 57: 1326-1328.
7. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 2010; 81: 428-432.
8. Bigal ME, Pipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 2006; 67: 252-257.
9. Rose FC. Trigger factors and the natural history of migraine. Funct Neurol 1986; 1: 379-384.
10. Masters JB, Mortimer MJ, Hay KM. Glucose and diet in fasting migraineurs. Headache 1986; 1: 379-384.
11. Lind L, Berne C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens 1995; 13: 1457-1462.
12. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Horwitz RI. Insulin resistance and risk for stroke. Neurology 2002; 59: 809-815.
13. Porte D, Baskin DG, Schwartz MW. Insulin signaling in the central nervous system. Diabetes 2005; 54: 1264-1276.
14. Rainero I, Limone P, Ferrero M. Insulin sensitivity is impaired in patients with migraine. Cephalalgia 2005; 25: 593-597.
15. Guldiken B, Guldiken S, Demir M, et al. Insulin resistance and high sensitivity C-reactive protein in migraine. Can J Neurol Sci 2008; 35: 448-451.
16. Beck AT, Ward C, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
17. World Health Organization. Obesity: Preventing and Managing in Global Epidemic. Report of a WHO consultation on obesity. Geneva: World Health Organization, 1997.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
19. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
20. Codwell EA, Ratcliff WA, Beastall GH, Ratcliff IG. Laboratory assessment of prolactin status. Ann Clin Biochem 1979; 16: 113-121.
21. Bhoi SK, Kalita J, Misra UK. Metabolic syndrome and insulin resistance in migraine. J Headache Pain 2012; 13: 321-326.
22. Guldiken B, Guldiken S, Taskiran B, et al. Migraine in metabolic syndrome. Neurologist 2009; 15: 55-58.
23. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache 2006; 46: 1334-1343.
24. Katsarava Z, Schneeweiss S, Kurth T, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004; 62: 788-790.
25. Yudkin JS. Insulin resistance and the metabolic syndrome - or the pitfalls of epidemiology. Diabetologia 2007; 50: 1576-1586.
26. Chan JC, Tong PC, Critchley JA. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk. Semin Vasc Med 2002; 2: 45-57.
27. Mezei Z, Kis B, Gecse A, et al. Platelet arachidonate cascade of migraineurs in the interictal phase. Platelets 2000; 11: 222-225.
28. Tietjen GE, Al-Qasmi MM, Athanas K, Dafer RM, Khuder SA. Increased Von Willebrand factor in migraine. Neurology 2001; 57: 334-336.
29. Horev A, Wirguin I, Lantsberg L, Ifergane G. A high incidence of migraine with aura among morbidly obese women. Headache 2005; 45: 936-938.
30. Masters JB, Mortimer MJ, Hay KM. Glucose and diet in fasting migraineurs. Headache 1986; 26: 243-247.
31. Vega GL. Is intra-abdominal obesity a unique risk factor for metabolic syndrome in non-diabetics? Indian J Med Res 2010; 131: 603-605.
32. Winter AC, Berger K, Buring JE, Kurth T. Body mass index, migraine, migraine frequency, and migraine features in women. Cephalalgia 2009; 29: 269-278.
33. Cavestro C, Rosatello A, Micca G, et al. Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache 2007; 47: 1436-1442.
34. Kim C, Siscovick DS, Sidney S, et al. Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: the CARDIA study: Coronary Artery Risk Development in Young Adults. Diabetes Care 2002; 25: 1027-1032.
35. Nielsen JH, Svensson G, Galsgaard ED, Moldrup A, Billestrup N. Beta cell proliferation and growth factors. J Mol Med 1999; 77: 62-66.
36. Bosco D, Labate A, Mungari P, Vero S, Fava A. SUNCT and high nocturnal prolactin levels: some new unusual characteristics. J Headache Pain 2007; 8: 114-118.
37. Bosco D, Belfiore A, Fava A, et al. Relationship between high prolactin levels and migraine attacks in patients with microprolactinoma. J Headache Pain 2008; 9: 103-107.